Literature DB >> 9357793

Intracellular mechanisms underlying prostaglandin F2alpha-stimulated phasic myometrial contractions.

M Phillippe1, T Saunders, A Basa.   

Abstract

These studies sought to test the hypothesis that prostaglandin F2alpha (PGF2alpha)-stimulated phasic myometrial contractions are characterized by the activation of the phosphatidylinositol-signaling pathway resulting in the generation of cytosolic calcium oscillations. For the experiments described in this report rat myometrial tissue was used, after the tissue was loaded with fura 2, to perform cytosolic calcium imaging studies and to perform computer-digitalized in vitro isometric contraction studies. Consistent with the above hypothesis, the cytosolic calcium-imaging studies demonstrated PGF2alpha-stimulated cytosolic calcium oscillations occurring simultaneously with phasic contractions. The in vitro isometric contraction studies confirmed that previously reported inhibitors of the phosphatidylinositol-signaling pathway and cytosolic calcium oscillation mechanisms resulted in significant inhibition of PGF2alpha-stimulated phasic myometrial contractions. In summary, these studies have provided substantial support for the hypothesis that PGF2alpha-stimulated phasic myometrial contractions are generated by intracellular signaling mechanisms involving activation of the phosphatidylinositol-signaling pathway and the production of cytosolic calcium oscillation-like phenomena.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357793     DOI: 10.1152/ajpendo.1997.273.4.E665

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.

Authors:  Oliver Pohl; Line Marchand; Jean-Pierre Gotteland; Simon Coates; Jörg Täubel; Ulrike Lorch
Journal:  Br J Clin Pharmacol       Date:  2018-06-05       Impact factor: 4.335

2.  The role of phospholipase Cgamma1 tyrosine phosphorylation during phasic myometrial contractions.

Authors:  Mark Phillippe; Leigh M Sweet; Daniel Engle
Journal:  Am J Obstet Gynecol       Date:  2007-02       Impact factor: 8.661

3.  A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway.

Authors:  Eugénie Goupil; Danaë Tassy; Carine Bourguet; Christiane Quiniou; Veronica Wisehart; Darlaine Pétrin; Christian Le Gouill; Dominic Devost; Hans H Zingg; Michel Bouvier; Horacio Uri Saragovi; Sylvain Chemtob; William D Lubell; Audrey Claing; Terence E Hébert; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.